ReviewAnnals of medicine and surgery (2012)2024

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease.

Ajeet Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.